首页> 外国专利> 1.3 - disustituida pyrrolidine derivative Compounds, process of preparation,Pharmaceutical Composition and use of the compound in the treatment of any State that meets the alpha2 adrenoceptor antagonists, such as Depression and schizophrenia.

1.3 - disustituida pyrrolidine derivative Compounds, process of preparation,Pharmaceutical Composition and use of the compound in the treatment of any State that meets the alpha2 adrenoceptor antagonists, such as Depression and schizophrenia.

机译：1.3-双嘧啶吡咯烷衍生物化合物，其制备方法，药物组合物和该化合物在治疗中遇到的任何满足α2肾上腺素受体拮抗剂的状态，例如抑郁症和精神分裂症。

页面导航

摘要
著录项
相似文献

摘要

The Invention provides compounds of the formula where R0, R1, R2, and a are as defined in the description and its preparation.The compounds of formula I are useful as Pharmaceuticals.

机译：本发明提供了下式的化合物，其中R 0，R 1，R 2和a如说明书及其制备中所定义。式I的化合物可用作药物。

著录项

公开/公告号CL2001000203A1

专利类型
公开/公告日2001-11-23

原文格式PDF
申请/专利权人 NOVARTIS AG;
展开▼

申请/专利号CL2001000203
发明设计人 NOZULAK JOACHIM;SEILER MAX PETER;
展开▼

申请日2001-01-26
分类号A61K31/402;A61K31/4025;A61P25/16;A61P25/18;A61P25/24;A61P27/06;C07D207/06;C07D213/64;C07D401/06;C07D403/06;C07D405/06;C07D405/12;C07D413/06;
国家 CL
入库时间 2022-08-22 00:45:55

相似文献

专利
外文文献
中文文献